Stay updated with breaking news from Cingulate Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
26.04.2022 - KANSAS CITY, Kan., April 26, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology to build and advance a ...
Cingulate (NASDAQ:CING – Get Rating) released its quarterly earnings data on Thursday. The company reported ($0.32) EPS for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.07, MarketWatch Earnings reports. Shares of CING remained flat at $$1.19 during midday trading on Friday. 17,376 shares of the stock traded hands, compared to its average volume […]
Cingulate to Present at Aegis Virtual Conference - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
NEW YORK, NY / ACCESSWIRE / December 10, 2021 / Aegis Capital Corp. acted as Lead Bookrunning Manager on a $25 Million Initial Public Offering of Common Stock for Cingulate Inc. (NASDAQ:CING).Cingulate